Seeking Alpha

Bristol-Myers Squibb (BMY) licenses the rights to sell several of its top-selling medicines in...

Bristol-Myers Squibb (BMY) licenses the rights to sell several of its top-selling medicines in Latin America to Reckitt Benckiser (RBGPY.PK) for $482M. Under the deal, the British company will be able to sell the medicines in countries such as Brazil and Mexico, and it has an option to acquire the brands outright after three years. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs